Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to make HIV prevention shots more accessible through flexible Follow-Up options

NCT ID NCT07335289

Summary

This study tests whether offering people a choice of where to receive follow-up care (at home, in the community, or at a clinic) helps them continue getting their twice-yearly HIV prevention injection. The research focuses on making this effective prevention method more accessible and easier to stick with over time. The study will enroll 400 HIV-negative people in Massachusetts who are eligible for HIV prevention medication.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PRE-EXPOSURE PROPHYLAXIS USE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Massachusetts General Hospital Sexual Health Clinic

    Boston, Massachusetts, 02114, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.